Nantkwest, Inc.
Records under this name other than the patents Nantkwest, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,258,649 | Tumoricidal and Antimicrobial Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 10,517,895 | Tumoricidal and Antimicrobial Compositions and Methods Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,646,516 | Tumoricidal and Antimicrobial Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 10,772,912 | A Tumoricidal and Antimicrobial Composition Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,213,547 | Tumoricidal and Antimicrobial Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 11,304,977 | Tumoricidal and Antimicrobial Compositions and Methods Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,975,027 | Tumoricidal and Antimicrobial Compositions and Methods Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,064,450 | Tumoricidal and Antimicrobial Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 10,456,420 | Genetically Modified NK-92 Cells and Monoclonal Antibodies for the Treatment of Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,736,921 | Genetically Modified NK-92 Cells and Monoclonal Antiboides for the Treatment of Cancer Formerly held In force · High confidence | In force | High confidence |